In a recent study published in the journal Nature Medicine, an international team of researchers evaluated the efficacy, safety, and tolerability of extended-release ketamine tablets (R-107) in adult ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved ...
AHMEDABAD, India--(BUSINESS WIRE)--Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) announces the launch of ...
MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...
(RTTNews) - Amneal Pharmaceuticals (AMRX) announced it has received FDA approval of its New Drug Application for Pyridostigmine Bromide Extended-Release Tablets USP 105 mg. PB ER 105 mg tablets are a ...
The Prader-Willi Syndrome Association USA estimates that PWS occurs in one in every 15,000 live births. The hallmark symptom of this disorder is hyperphagia, a chronic and life-threatening condition ...
Onyda XR should not be substituted for other clonidine products on a mg-per-mg basis. The Food and Drug Administration (FDA) has approved Onyda XR (clonidine hydrochloride) extended-release oral ...
Granules India Ltd on Thursday said its arm Granules Pharmaceuticals, Inc has received tentative approval from the US health regulator for its generic amphetamine extended-release tablets indicated ...
December 7, 2009 — The US Food and Drug Administration (FDA) has approved a new indication for quetiapine fumarate extended-release tablets (Seroquel XR, AstraZeneca Pharmaceuticals, LP), allowing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results